Our world-class team is comprised of experts in cancer biology, medicinal chemistry, next-generation chemical proteomics, computational chemistry and molecular biophysics, machine learning, and drug development.
Developing the next generation of targeted cancer therapies
Our mission is to optimize and deliver transformational therapies for larger populations of patients with cancer.
Our fully integrated discovery platform is built upon the most advanced technologies available for drug discovery, small molecule design, and target identification that we believe will enable us to rapidly create highly selective small molecule compounds against an unprecedented spectrum of targets.
We envision a world in which selective small molecule therapies can be quickly created and used against an unprecedented spectrum of targets to enable people with cancer to live fuller, longer lives.
Board of Directors